Background The US overdose crisis is driven by fentanyl, heroin, and prescription opioids.
One evidence-based policy response has been to broaden naloxone distribution, but how …

The evolving nature of the opioid epidemic and continued increases in overdose deaths
highlight a need for fundamental change in the collection and use of surveillance data to link …

The opioid crisis is a major public health challenge in the United States, killing about 70,000
people in 2020 alone. Long delays and feedbacks between policy actions and their effects …

Opioid overdose deaths remain a major public health crisis. We used a system dynamics
simulation model of the US opioid-using population age 12 and older to explore the impacts …

Importance Most prisons and jails in the US discontinue medications for opioid use disorder
(MOUD) upon incarceration and do not initiate MOUD prior to release. Objective To model …

Importance In 2017, the US Food and Drug Administration (FDA) approved a monthly
injectable form of buprenorphine, extended-release buprenorphine; published data show …

Importance Improving access to naloxone is a critical component of the nation's strategy to
curb fatal overdoses in the opioid crisis. Standing or protocol orders, prescriptive authority …

Abstract Background and Aims While the United States is in the midst of an overdose
epidemic, effective treatments are underutilized and commonly discontinued. Innovations in …

Importance Overdose is the leading cause of death among people experiencing
homelessness (PEH), but engagement in medication treatment is low in this population …

Abstract The Helping End Addictions Long Term (HEALing) Communities Study (HCS)
seeks to significantly reduce overdose deaths in 67 highly impacted communities in …